Neudle.com: Devic s disease

Differential
(Click to cross reference)

abdominal reflex, absent

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

activated protein C resistance

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

alcohol

alemtuzumab

algorithm

amphiphysin antibodies

amphotericin B

ANA

angiotensin-converting enzyme

anti MAG antibodies

anti Ro antibody

anticardiolipin antibodies

anticoagulant, treatment

antiphospholipid antibodies

antithrombin III deficiency

area postrema

area postrema syndrome

basal ganglia, lesion of

blood dyscrasias, neurologic findings with

cardiac arrest and resuscitation

cardiomyopathy

CAT scan

CAT scan, abnormal

CAT scan, delta sign, empty

cerebral edema, vasogenic

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, cost of

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, mimics

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease, risk factors in

cerebrovascular disease, treatment of

chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids

Clinical Pathologic Conference(C.P.C.)

clofibrate

coagulopathy

collapsin response mediator protein 5 IgG

controversies in neurology

conus medullaris vs.cauda equina lesion

conus medullaris, lesion of

conversion reaction

corpus callosum

corpus callosum, lesion of

cost

cost effectiveness

craniectomy, decompressive

critical care unit

cytokines

cytomegalovirus infection

demyelinating disease

dermatomyositis

diagnostic criteria

diencephalon

differential diagnosis

diplopia

dipyridamole

disability, neurological

disseminated intravascular coagulation(DIC)

diuretic

drug induced neurologic disorders

dural sinus thrombosis

dysarthria

eculizumab

efficacy

electrocardiogram, abnormal

electroencephalogram, abnormalities of

embolism

embolism, cholesterol

embolism, platelet

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

endovascular therapy

enolase

enzyme, muscle disease

epidemiology of neurology

epsilon-aminocaproic acid(E.A.C.A.)

evidence-based research

fibrinolytic agents, intra-venous local infusion

fibromyalgia

fourth ventricle, floor

gadolinium

gammaglobulin therapy, intravenous

gender

gene mutation

genetic neurologic disorders

genetic testing

gray matter

Guillain Barre syndrome

head injury

head injury, pediatric

hemoglobin abnormality, neurologic complications of

heralding manifestation

hiccoughs

hiccoughs, intractable

HLA

human immunodeficiency virus type 1

hyponatremia with cerebral disorders

hypothalamus

hypothalamus, damage to

hypothalamus, lesion of

hypothermia

hypoxic encephalopathy

iatrogenic neurologic disorders

idiopathic

immunohistochemistry

immunomodulation

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

intellectual deterioration

internal capsule

interobserver agreement

intracerebral hemorrhage

intracranial hypertension, benign

intracranial pressure, increased

ipecac

Japan

jaw claudication

lesions too numerous to count

leukemia

leukemia, neurologic findings assoc.with

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

lipoprotein receptor-related protein 4

liquorice

lumbosacral radiculopathy

lupus anticoagulant

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

mammillary bodies

McDonald criteria for MS

medulla oblongata

medulla oblongata, lesion of

meningeal enhancement

meningitis

mental status, abnormal

microangiopathy, spinal cord

microemboli

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

middle cerebral artery territory infarction

middle cerebral artery, occlusion of

monoclonal antibodies

mortality

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

MRI, spinal cord, increased intramedullary cord signal

MRI, susceptibility weighted

multiple sclerosis, clinical patterns

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, late-onset

multiple sclerosis, misdiagnosis

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

multiple sclerosis, without CSF bands

multiple sclerosis, work up for

multiple system atrophy

muscle weakness, causes of

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, post infectious

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, prognosis

myelitis, transverse, recurrent

myelopathy, necrotizing

myeloproliferative disorder

myopathy, drug-induced

myopathy, hypokalemic

myopathy, proximal

myopathy, steroid induced

natalizumab

nausea and vomiting

negative

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination, focal

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica (Devic's disease), screening

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuron specific enolase

neuropathology

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral, treatment

NMDA antagonists

nonsteroidal anti-inflammatory drug

Oculinum

old age, neurology of

ophthalmoplegia

opportunistic infection

optic chiasm

optic chiasm, lesion of

optic nerve

optic nerve, enhancement

optic nerve, lesion of

optic neuritis

optic neuritis, alternating

optic neuritis, bilateral

optic neuritis, recurrent

optic neuropathy

optic neuropathy, ischemic

optical coherence tomography

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

ovarian tumor

owl's eye sign of spinal cord

Parkinsonism syndrome

paroxysmal nocturnal hemoglobinuria

pathology

perhexiline maleate

periaqueductal lesion

plasminogen deficiency

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polycythemia, primary

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

pregnancy, neurologic complications in

prethrombotic state

prevention of neurologic disorders

primary thrombocythemia

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

scleroderma, neurologic involvement with

screening

sedimentation rate, elevated

seizure

sensory level

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

somnolence

spinal cord

spinal cord, biopsy

spinal cord, compression of

spinal cord, dorsal subpial enhancement

spinal cord, enlargement

spinal cord, infarction of

spinal cord, lesion of

spinal cord, neoplasm

splenium of corpus callosum

staphylococcal protein A column therapy

steroid

steroid therapy, CNS treatment and complications with

straight sinus

subarachnoid hemorrhage

sulfinpyrazone

superior sagittal sinus thrombosis

sweet taste

symmetric brain lesions

syringomyelia

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of

thalamus, lesion of-bilateral

third ventricle, wall

tissue plasminogen activator, intravenous

tongue, fasciculations of

tonic spasms

toxoplasma gondii

transient ischemic attack

transient ischemic attack, treatment of

transient neurologic deficit

treatment of neurologic disorder

vincristine neurotoxicity

viral infection

vision loss, sequential

vision, blurred

visual acuity

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

vomiting, intractable

Wallerian degeneration

water channel antibodies

weakness

weakness, acute

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease

white matter disease, periventricular

whites

workup

Showing articles 50 to 100 of 140 << Previous Next >>

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Neuromyelitis Optica and Pregnancy
Neurol 78:875-879, Bourre,B.,et al, 2012

Distinct Lesion Morphology at 7-T MRI Differentiates Neuromyelitis Optica from Multiple Sclerosis
Neurol 79:708-714, Sinnecker, T.,et al, 2012

Painful Tonic Spasm in Neuromyelitis Optica
Arch Neurol 69:1026-1031, Kim, S.M.,et al, 2012

Two Cases of Lumbosacral Myeloradiculitis with Anti-Aquaporin-4 Antibody
Neurol 79:1826-1828, Takai, Y.,et al, 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International ID 735486, Kim, W.,et al, 2012

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

Azathioprine
Neurol 77:659-666, Costanzi, C.,et al, 2011

Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
Neurol 77:1644-1645, Iorio, R.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Familial Neuromyelitis Optica
Neurol 75:310-315, Matiello,M., et al, 2010

Neuromyelitis Optica Treatment: Analysis of 36 Patients
Arch Neurol 67:1131-1136, Bichuetti,D.B.,et al, 2010

Hiccups, Nausea, and Vomiting: Water Channels Under Attack
Lancet 375:394, Riphagen,J.,et al, 2010

Neuromyelitis Optica in France: A Multicenter Study of 125 Patients
Neurol 74:736-742, Collongues,N.,et al, 2010

Longitudinally Extensive Myelopathy in Caucasians: A West Australian Study of 26 Cases from the Perth Demyelinating Diseases Database
JNNP 81:209-212, Qiu,W.,et al, 2010

Neuromyelitis Optica and Concentric Rings of Bal� in the Brainstem
Arch Neurol 66:274-275, Graber,J.J.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009

Nineteen Episodes of Recurrent Myelitis in a Woman with Neuromyelitis Optica and Systemic Lupus Erythematosus
Arch Neurol 66:1160-1163, Nasir, S.,et al, 2009

Treatment of Neuromyelitis Optica with Mycophenolate Mofetil
Arch Neurol 66:1128-1133, Jacob,A.,et al, 2009

A Woman With Acute Myelopathy in Pregnancy: Case Outcome
BMJ 339:1372-1376, Reu�,R.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

"Cloud-like Enhancement" Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica
Ann Neuro l 66:425-428, Ito, S.,et al, 2009

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

To Test or Not to Test: NMO-IgG and Optic Neuritis
Neurol 70:2192-2193, Giovannoni,G., 2008

NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

NMO Antibody-Positive Recurrent Optic Neuritis Without Clear Evidence of Transverse Myelitis
Arch Ophthalmol 126:566-570, Dinkin,M.J.,et al, 2008

Brain Magnetic Resonance Imaging Abnormalities in Neuromyelitis Optica
Acta Neurol Scand 118:218-225, Li, Y.,et al, 2008

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

NMO-IgG in the Diagnosis of Neuromyelitis Optica
Neurol 68:1076-1077, Jarius,S.,et al, 2007

Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006

Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006

Showing articles 50 to 100 of 140 << Previous Next >>